Instructions to register a Yale sponsored trial on ClinicalTrials.gov
The ClinicalTrials.gov Protocol Registration System (PRS) is a web-based tool developed for submitting clinical trials information to ClinicalTrials.gov. Records submitted through the PRS (http://register.clinicaltrials.gov) are available to the public at ClinicalTrials.gov. A guided tour of the PRS and account application information are available at http://prsinfo.clinicaltrials.gov/
PRS users enter information about their clinical trials, ensuring that the information is correct, readily understood by members of the public, and updated in a timely manner.
For clinical trial results to be considered for publication in journals that adhere to the International Committee of Medical Journal Editors (ICMJE) standards, the ICMJE has mandated that all clinical trials which begin recruiting on or after July 1, 2005 must be registered with a public registry before the enrollment of the first patient. The registry and its content must meet certain criteria in order to be considered acceptable. Details are described at the International Committee of Medical Journal Editors Web site.
Yale University is registered as an institution with ClinicalTrials.gov. ClinicalTrials.gov asks each institution to identify a Protocol Registration System (PRS) Administrator. Tesheia Johnson, Associate Director of Clinical Research, for Yale School of Medicine and Chief Operations Officer for the Yale Center for Clinical Investigations has been named to that role for the School of Medicine.
Request a Yale user account
- Send an e-mail message to one of the following administrators with the subject line: ClinicalTrials.gov account request
- In the body of the email include the names and email addresses of the individuals for which you are requesting an account.
- An email will be sent notifying the individuals that the account has been established and providing you with a log-in name and temporary password for ClinicalTrials.gov, along with full instructions for registering your trial.